Search research articles
Contact Us
Filters
Showing results (81-90 of 123) with videos related to
Page
of 13
Sort By:
International Journal of Molecular Sciences
|
November 11, 2022
Biological Cover Mitigates Disruption of the Dermal Structure in Mechanically Expanded Skin in a Porcine Model
Joanna K Ledwon, Sarah A Applebaum, Bianka Progri, et al.
JCO Clinical Cancer Informatics
|
December 9, 2021
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group
Anoop Mayampurath, Siddhi Ramesh, Diana Michael, et al.
Cancer Metastasis Reviews
|
December 15, 2019
Progress toward liquid biopsies in pediatric solid tumors
Daniel A Weiser, Diana C West-Szymanski, Ellen Fraint, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
5-hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma
Mohansrinivas Chennakesavalu, Kelley Moore, Gepoliano Chaves, et al.
JCO Precision Oncology
|
January 31, 2024
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma
Mohansrinivas Chennakesavalu, Kelley Moore, Gepoliano Chaves, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma
Omar R Vayani, Maria E Kaufman, Kelley Moore, et al.
Research Square
|
September 15, 2025
5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma
Evan W Neczypor, Hailey Reisert, Kelley Moore, et al.
Pediatric Blood & Cancer
|
October 20, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma
Omar R Vayani, Maria E Kaufman, Kelley Moore, et al.
NPJ Precision Oncology
|
February 11, 2026
5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma
Evan W Neczypor, Hailey Reisert, Kelley Moore, et al.
JAMA Network Open
|
July 8, 2021
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma
Skye Balyasny, Sang Mee Lee, Ami V Desai, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 123) with videos related to
Sort By:
Page
of 13
International Journal of Molecular Sciences
|
November 11, 2022
Biological Cover Mitigates Disruption of the Dermal Structure in Mechanically Expanded Skin in a Porcine Model
Joanna K Ledwon, Sarah A Applebaum, Bianka Progri, et al.
JCO Clinical Cancer Informatics
|
December 9, 2021
Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group
Anoop Mayampurath, Siddhi Ramesh, Diana Michael, et al.
Cancer Metastasis Reviews
|
December 15, 2019
Progress toward liquid biopsies in pediatric solid tumors
Daniel A Weiser, Diana C West-Szymanski, Ellen Fraint, et al.
Biorxiv : the Preprint Server for Biology
|
May 10, 2023
5-hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma
Mohansrinivas Chennakesavalu, Kelley Moore, Gepoliano Chaves, et al.
JCO Precision Oncology
|
January 31, 2024
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma
Mohansrinivas Chennakesavalu, Kelley Moore, Gepoliano Chaves, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma
Omar R Vayani, Maria E Kaufman, Kelley Moore, et al.
Research Square
|
September 15, 2025
5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma
Evan W Neczypor, Hailey Reisert, Kelley Moore, et al.
Pediatric Blood & Cancer
|
October 20, 2023
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma
Omar R Vayani, Maria E Kaufman, Kelley Moore, et al.
NPJ Precision Oncology
|
February 11, 2026
5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma
Evan W Neczypor, Hailey Reisert, Kelley Moore, et al.
JAMA Network Open
|
July 8, 2021
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma
Skye Balyasny, Sang Mee Lee, Ami V Desai, et al.
Page
of 13